-transparent.png){kind=logo}
Radiation therapy is the only potentially curative form of therapy for patients with carcinoma of the lung who are not surgical candidates. Previous studies have evaluated response by evaluating survival. Evaluation of local control of disease is essential if one is to understand and modify therapeutic approaches in an effort to increase survival. Clinical data are presented on 197 patients with primary epithelial tumors of the lung. An analysis of local control data is presented using the concept of nomial standard dose (NSD). If local failure is to occur, it is manifest by 15 months. Survival is affected by the ability or inability to achieve local control. Above a dose of 1450 ret, no correlation between increasing ret dose and increasing local control is observed.
D R Eisert, and
J D Cox, and
R Komaki
July 1995,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
D R Eisert, and
J D Cox, and
R Komaki
March 1983,
Clinical radiology,
D R Eisert, and
J D Cox, and
R Komaki
May 1986,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
D R Eisert, and
J D Cox, and
R Komaki
April 1987,
International journal of radiation oncology, biology, physics,
D R Eisert, and
J D Cox, and
R Komaki
June 1975,
The Laryngoscope,
D R Eisert, and
J D Cox, and
R Komaki
April 1996,
Thorax,
D R Eisert, and
J D Cox, and
R Komaki
May 1986,
International journal of radiation oncology, biology, physics,
D R Eisert, and
J D Cox, and
R Komaki
January 1986,
Radiation medicine,
D R Eisert, and
J D Cox, and
R Komaki
February 1994,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
D R Eisert, and
J D Cox, and
R Komaki
May 1979,
Radiology,
